Sensitivity and validity of psychometric tests for assessing driving impairment: Effects of sleep deprivation

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Jongen, Stefan ^a   Perrier, Joy ^a,b   Vuurman, Eric F ^a   Ramaekers, Johannes G ^a   Vermeeren, Annemiek ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTENTION NETWORK TEST; CONCEPT SHIFTING TASK; CONTROLLED STUDY; CRITICAL TRACKING TASK; DETERMINATION TEST; DIGIT SYMBOL SUBSTITUTION TEST; DIVIDED ATTENTION TEST; DRIVING ABILITY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; POSTURAL BALANCE TEST; PSYCHOMETRY; PSYCHOMOTOR VIGILANCE TEST; RESPONSE TIME; SENSITIVITY AND SPECIFICITY; SLEEP DEPRIVATION; USEFUL FIELD OF VIEW TEST; VALIDATION STUDY; CAR DRIVING; MIDDLE AGED; PROCEDURES; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE; REPRODUCIBILITY; SLEEP STAGE; YOUNG ADULT;

ADULT; AUTOMOBILE DRIVING; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; PSYCHOMOTOR PERFORMANCE; REPRODUCIBILITY OF RESULTS; SLEEP DEPRIVATION; SLEEP STAGES; YOUNG ADULT;

EID: 84922818314     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117045     Document Type: Article

References (82)

1. O 'Hanlon JF, Haak TW, Blaauw GJ, Riemersma JB (1982) Diazepam impairs lateral position control in highway driving. Science 217(4554): 79-81. PMID: 7089544
2. O 'Hanlon JF (1984) Driving performance under the influence of drugs: rationale for, and application of, a new test. Br J Clin Pharmacol 18 Suppl 1: 121-129. PMID: 6525328
3. Seppala T, Linnoila M, Mattila M (1979) Drugs, alcohol and driving. Drugs 17(5): 389. PMID: 37067
4. Vingilis E, Macdonald S (2002) Review: Drugs and Traffic Collisions. Traffic Inj Prev 3(1): 1-11.
5. Walsh JM, de Gier JJ, Christopherson AS, Verstraete AG (2004) Drugs and driving. Traffic Inj Prev 5 (3): 241-253. PMID: 15276925
6. O 'Hanlon J (1986) Performance testing as part of drug registration. In: Drugs and Driving. London: Taylor and Francis. 402 p.
7. Verstraete A, Knoche A, Jantos R, Skopp G (2011) Per se limits-Methods of defining cut off values for zero tolerance. Deliverable 142, DRUID (Driving under the Influence of Drugs, Alcohol and Medicines)th framework programme. Available at http://www.druid-project.eu/ Accessed 10 December 2013.
8. Ramaekers JG (2003) Antidepressants and driver impairment: empirical evidence from a standard on-the-road test. The Journal of clinical psychiatry 64(1): 20-29. PMID: 12590619
9. International Council on Alcohol Drugs and Traffic Safety (ICADTS) (1999) Guidelines on experimental studies undertaken to determine a medicinal drug's effect on driving or skills related to driving. Bundes Anstalt fuer Strassenwesen (BASt), Cologne, p 1-13.
10. Kay G, Logan B (2011) Drugged Driving Expert Panel Report: A Consensus Protocol for Assessing the Potential of Drugs to Impair Driving. Washington DC: National Highway Traffic Safety Administration. PMID: 22553853
11. Vermeeren A, De Gier JJ, O'Hanlon JF (1994) Methodological guidelines for experimental research on medicinal drugs affecting driving performance: an international expert survey. J Traffic Med, 22(4), 173-174.
12. Walsh JM, Verstraete AG, Huestis MA, Mørland J (2008) Guidelines for research on drugged driving. Addiction 103(8): 1258-1268. doi: 10.1111/j.1360-0443.2008.02277.x PMID: 18855814
13. Verster JC, Roth T (2011) Standard operation procedures for conducting the on-the-road driving test, and measurement of the standard deviation of lateral position (SDLP). Int J Gen Med 4: 359-371. doi: 10.2147/IJGM.S19639 PMID: 21625472
14. Borkenstein F, Crowther RF, Shumate RP, Zeil WB, Zylman R (1964) The role of the drinking driver in traffic accidents. Indiana University, Bloomington.
15. th framework programme. Available at http://www.druid-project.eu/. Accessed 10 December 2013.
16. Brookhuis KA, Waard DD, Fairclough SH (2003) Criteria for driver impairment. Ergonomics 46(5): 433-445. PMID: 12745694
17. Van Steveninck AL, Van Berckel BNM, Schoemaker RC, Breimer DD, Van Gerven et al. (1999) The sensitivity of pharmacodynamic tests for the central nervous system effects of drugs on the effects of sleep deprivation. Journal of Psychopharmacology 13(1): 10-17. PMID: 10221355
18. Connor J, Norton R, Ameratunga S, Robinson E, Civil I, et al. (2002) Driver sleepiness and risk of serious injury to car occupants: population based case control study. BMJ 324(7346): 1125. PMID: 12003884
19. Horne JA, Reyner LA (1995) Sleep related vehicle accidents. BMJ 310(6979): 565-567. PMID: 7888930
20. Akerstedt T, Kecklund G, Hörte LG (2001) Night driving, season, and the risk of highway accidents. Sleep 24(4): 401-406. PMID: 11403524
21. Martiniuk AL, Senserrick T, Lo S, Williamson A, Du W, et al. (2013) Sleep-deprived young drivers and the risk for crash: the DRIVE prospective cohort study. JAMA pediatr 167(7): 647-655. doi: 10.1001/ jamapediatrics.2013.1429 PMID: 23689363
22. Valent F, Di Bartolomeo S, Marchetti R, Sbrojavacca R, Barbone F (2010) A case-crossover study of sleep and work hours and the risk of road traffic accidents. Sleep 33(3): 349. PMID: 20337193
23. Baulk SD, Biggs SN, Reid KJ, van den Heuvel CJ, Dawson D (2008) Chasing the silver bullet: measuring driver fatigue using simple and complex tasks. Accid Anal Prev 40(1): 396-402. doi: 10.1016/j.aap. 2007.07.008 PMID: 18215574
24. Bosker WM, Kuypers KP, Conen S, Ramaekers JG (2010) Dose-related effects of MDMA on psychomotor function and mood before, during, and after a night of sleep loss. Psychopharmacology 209(1): 69-76. doi: 10.1007/s00213-009-1767-1 PMID: 20084368
25. Gillberg M, Åkerstedt T (1998) Sleep loss and performance: no "safe" duration of a monotonous task. Physiology & behavior 64(5): 599-604. doi: 10.1016/j.domaniend.2014.12.002 PMID: 25616248
26. Jackson ML, Croft RJ, Kennedy GA, Owens K, Howard ME (2013) Cognitive components of simulated driving performance: sleep loss effects and predictors. Accid Anal Prev 50: 438-444. doi: 10.1016/j. aap.2012.05.020 PMID: 22721550
27. Kuypers KPC, Wingen M, Samyn N, Limbert N, Ramaekers JG (2007) Acute effects of nocturnal doses of MDMA on measures of impulsivity and psychomotor performance throughout the night. Psychopharmacology 192(1): 111-9. PMID: 17219216
28. Lamond N, Dawson D (1999) Quantifying the performance impairment associated with fatigue. J Sleep Res 8(4): 255-262. PMID: 10646165
29. Williamson AM, Feyer AM (2000) Moderate sleep deprivation produces impairments in cognitive and motor performance equivalent to legally prescribed levels of alcohol intoxication. Occup Environ Med 57(10): 649-655. PMID: 10984335
30. Doran S (2001) Sustained attention performance during sleep deprivation: evidence of state instability. Arch Ital Biol 139(3): 253-267. PMID: 11330205
31. Jewett ME, Dijk DJ, Kronauer RE, Dinges DF (1999) Dose-response relationship between sleep duration and human psychomotor vigilance and subjective alertness. Sleep 22(2): 171-179. PMID: 10201061
32. Lim J, Dinges DF (2008) Sleep deprivation and vigilant attention. Annals of the New York Academy of Sciences 1129(1): 305-322.
33. Schuhfried G (2005) Manual Expert System Traffic (XPSV). Mödling: Schuhfried GmbH
34. Brunnauer A, Laux G, David I, Fric M, Hermisson I, et al. (2008) The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients. J Clin Psychiatry 69(12): 1880-1886. PMID: 19203476
35. Greenblatt DJ, Legangneux E, Harmatz JS, Weinling E, Freeman J, et al. (2006) Dynamics and kinetics of a modified?release formulation of zolpidem: comparison with immediate?release standard zolpidem and placebo. J Clin Pharmacol 46(12): 1469-1480. PMID: 17101746
36. Moskowitz H (1973) Laboratory studies of the effects of alcohol on some variables related to driving J Sleep Res 1973(5): 185-199.
37. Robbe HW, O 'Hanlon JF (1995) Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers. Europ Neuropsychopharmacol 5(1) 35-42.
38. Roth T, Mayleben D, Corser BC, Singh NN (2008) Daytime pharmacodynamic and pharmacokinetic evaluation of low?dose sublingual transmucosal zolpidem hemitartrate. Hum Psychopharmacol 23(1): 13-20. PMID: 17907263
39. Forsman P, Pyykkö I, Toppila E, Hæggström E (2014) Feasibility of force platform based roadside drowsiness screening-A pilot study. Accid Anal Prev 62: 186-190. doi: 10.1016/j.aap.2013.09.015 PMID: 24172085
40. Jongen S, Vuurman E, Ramaekers J, Vermeeren A. (2014) Alcohol calibration of tests measuring skills related to car driving. Psychopharmacology 231(12): 2435-2447. doi: 10.1007/s00213-013-3408-y PMID: 24408210
41. Clark PG, Blissmer BJ, Greene GW, Lees FD, Riebe DA, et al. (2011) Maintaining exercise and healthful eating in older adults: The SENIOR project II: Study design and methodology. Contemp Clin Trials 32(1): 129-139. doi: 10.1016/j.cct.2010.10.002 PMID: 20955821
42. Silva MT, Laks J, Engelhardt E (2009) Neuropsychological tests and driving in dementia: a review of the recent literature. Revista da Associação Médica Brasileira 55(4): 484-488.
43. Myers RS, Ball KK, Kalina TD, Roth DL, Goode KT (2000) Relation of useful field of view and other screening tests to on-road driving performance. Percept Mot Skills 91(1): 279-90. PMID: 11011899
44. Weaver B, Bédard M, McAuliffe J, Parkkari M (2009) Using the Attention Network Test to predict driving test scores. Accid Anal Prev 41(1): 76-83. doi: 10.1016/j.aap.2008.09.006 PMID: 19114140
45. Louwerens J, Gloerich A, de Vries G, Brookhuis K, O'Hanlon J (1987) The relationship between drivers' blood alcohol concentration (BAC) and actual driving performance during high speed travel. In: Noordzij PC, Roszbach R, editors. Alcohol Drugs Traffic Safety-T86. Amsterdam: Elsevier. pp. 183-186. doi: 10.1080/15389588.2014.935356 PMID: 25436517
46. Vermeeren A, Riedel WJ, Van Boxtel MP, Darwish M, Paty I, et al. (2002) Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol. Sleep 25(2): 224-231. PMID: 11905433
47. O 'Hanlon JF, Ramaekers JG (1995) Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989?94. Allergy 50(3): 234-242. PMID: 7677241
48. Vuurman EFPM, Rikken GH, Muntjewerff ND, De Halleux F, Ramaekers JG (2004) Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements. European J Clin Pharmacol 60(5): 307-313. PMID: 15168099
49. Leufkens TR, Vermeeren A (2014) Zopiclone's Residual Effects on Actual Driving Performance in a Standardized Test: A Pooled Analysis of Age and Sex Effects in 4 Placebo-Controlled Studies. Clinical therapeutics 36(1): 141-150. doi: 10.1016/j.clinthera.2013.11.005 PMID: 24360801
50. Roth T, Eklov SD, Drake CL, Verster JC (2014) Meta-analysis of on-the-road experimental studies of hypnotics: effects of time after intake, dose, and half-life. Traffic Inj Prev 15(5): 439-445. doi: 10.1080/ 15389588.2013.830211 PMID: 24678565
51. Vermeeren A, Vuurman EF, Leufkens TR, Van Leeuwen CJ, Van Oers AC et al. (2013) Residual Effects of Low-Dose Sublingual Zolpidem on Highway Driving Performance the Morning after Middle-of-the-Night Use. Sleep 37(3): 489-496.
52. Bosker WM, Kuypers KPC, Conen S, Kauert GF, Toennes SW, et al. (2012) MDMA (ecstasy) effects on actual driving performance before and after sleep deprivation, as function of dose and concentration in blood and oral fluid. Psychopharmacology 222(3): 367-76. doi: 10.1007/s00213-011-2497-8 PMID: 21952668
53. Verster JC, Roth T (2012) Predicting psychopharmacological drug effects on actual driving performance (SDLP) from psychometric tests measuring driving-related skills. Psychopharmacology 220(2): 293-301. doi: 10.1007/s00213-011-2484-0 PMID: 21922169
54. th CINP Congress Florence. PMID: 25057717
55. Dinges D, Powell J (1985) Microcomputer analyses of performance on a portable, simple visual RT task during sustained operations. Behav Res Methods 17(6): 652-655.
56. Basner M, Dinges DF (2011) Maximizing sensitivity of the psychomotor vigilance test (PVT) to sleep loss. Sleep 34(5): 581. PMID: 21532951
57. Jex HR, McDonnell JD, Phatak AV (1966) A "critical" tracking task for man-machine research related to the operator's effective delay time. I. Theory and experiments with a first-order divergent controlled element. NASA CR-616. NASA contractor report. NASA CR. United States. National Aeronautics and Space Administration, 1-105.
58. Riedel WJ, Mehta MA, Unema PJ (2006) Human cognition assessment in drug research. Current pharmaceutical design 12(20): 2525-2539. PMID: 16842175
59. McLeod DR, Griffiths RR, Bigelow GE, Yingling J (1982) An automated version of the digit symbol substitution test (DSST). Behav Res Methods Instrum Comput 14(5): 463-466.
60. Leufkens TRM, Lund JS, Vermeeren A (2009) Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem. J Sleep Res 18(4): 387-96. doi: 10.1111/j.1365-2869.2009.00746.x PMID: 19552733
61. Fan J, McCandliss BD, Sommer T, Raz A, Posner MI (2002) Testing the efficiency and independence of attentional networks. Journal of cognitive neuroscience 14(3): 340-347. PMID: 11970796
62. Van der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J (2006) The Concept Shifting Test: adult normative data. Psychological Assessment 18: 424-432. PMID: 17154763
63. Mets MAJ, Volkerts ER, Olivier B, Verster JC (2010) Effect of hypnotic drugs on body balance and standing steadiness. Sleep Med Rev 14(4): 259-267. doi: 10.1016/j.smrv.2009.10.008 PMID: 20171127
64. Mets MAJ, de Vries JM, de Senerpont Domis LM, Volkerts ER, Olivier B, et al. (2011) Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects. Sleep 34(10): 1327-1334. doi: 10.5665/SLEEP.1272 PMID: 21966064
65. Edwards JD, Vance DE, Wadley VG, Cissell GM, Roenker DL, et al. (2005) Reliability and validity of useful field of view test scores as administered by personal computer. Journal of Clinical and Experimental Neuropsychology 27(5): 529-543. PMID: 16019630
66. Åkerstedt T, Gillberg M (1990) Subjective and objective sleepiness in the active individual. International Journal of Neuroscience 52(1- 2): 29-37. PMID: 2269606
67. Brookhuis KA, de Vries G, O'Hanlon JF (1985) The effects of increasing doses of meptazinol (100, 200,mg) and glafenine (200 mg) on actual driving performance. VK 85-16. Haren: Traffic Research Centre.
68. Dorrian J, Rogers NL, Dinges DF (2005) Psychomotor vigilance performance: Neurocognitive assay sensitive to sleep loss. PhD Thesis, University of Pensylvania School of Medicine. Available: https:// www.med.upenn.edu/uep/user-documents/Dorrianetal.PVTchapterinKushida2005.pdf. Accessed 10June 2012.
69. Dry MJ, Burns NR, Nettelbeck T, Farquharson AL, White JM (2012) Dose-related effects of alcohol on cognitive functioning. PloS one 7(11): e50977. doi: 10.1371/journal.pone.0050977 PMID: 23209840
70. Dunlap WP, Cortina JM, Vaslow JB, Burke MJ (1996) Meta-analysis of experiments with matched groups or repeated measures designs. Psychological Methods 1(2): 170-177.
71. Falleti MG, Maruff P, Collie A, Darby DG, McStephen M (2003) Qualitative similarities in cognitive impairment associated with 24 h of sustained wakefulness and a blood alcohol concentration of 0.05%. J Sleep Res 12(4): 265-274. PMID: 14633237
72. Boyle J, Danjou P, Alexander R, Calder N, Gargano C, et al. (2009) Tolerability, pharmacokinetics and night?time effects on postural sway and critical flicker fusion of gaboxadol and zolpidem in elderly subjects. British journal of clinical pharmacology 67(2): 180-190. doi: 10.1111/j.1365-2125.2008.03331.x PMID: 19094161
73. Howard ME, Jackson ML, Kennedy GA, Swann P, Barnes M, et al. (2007) The interactive effects of extended wakefulness and low-dose alcohol on simulated driving and vigilance. Sleep 30(10): 1334.PMID: 17969467
74. Leufkens TRM, Ramaekers JG, de Weerd AW, Riedel WJ, Vermeeren A. (2014) Residual effects of zopiclone 7.5 mg on highway driving performance in insomnia patients and healthy controls: a placebo controlled crossover study. Psychopharmacology: 1-14. doi: 10.1007/s00213-014-3807-8 PMID: 25407348
75. Rogé J, Pébayle T, Hannachi SE, Muzet A (2003) Effect of sleep deprivation and driving duration on the useful visual field in younger and older subjects during simulator driving. Vision research 43(13): 1465-1472. PMID: 12767314
76. Jugovac D, Cavallero C (2012) Twenty-four hours of total sleep deprivation selectively impairs attentional networks. Experimental psychology 59(3): 115-23. doi: 10.1027/1618-3169/a000133 PMID: 22044791
77. Martella D, Casagrande M, Lupiáñez J (2011) Alerting, orienting and executive control: the effects of sleep deprivation on attentional networks. Experimental brain research 210(1): 81-89. doi: 10.1007/ s00221-011-2605-3 PMID: 21390488
78. Dawson D, Reid K (1997) Fatigue, alcohol and performance impairment. Nature, 388(6639): 235. PMID: 9230429
79. Borbély AA (1982) A two process model of sleep regulation. Hum Neurobiol.
80. Owens K, Ramaekers JG (2009) Drugs, driving, and models to measure driving impairment. In Verster JC, Pandi-Perumal SR, Ramaekers JG, de Gier JJ, editors. Drugs, driving and traffic safety. Basel: Birkhäuser. pp. 43-58
81. Kleykamp BA, Griffiths RR, Mintzer MZ (2010) Dose effects of triazolam and alcohol on cognitive performance in healthy volunteers. Exp Clin Psychopharmacol 18(1): 1. doi: 10.1037/a0018407 PMID: 20158290
82. Tiplady B, Hiroz J, Holmes L, Drummond G (2003) Errors in performance testing: a comparison of ethanol and temazepam. Journal of Psychopharmacology 17(1): 41-49. PMID: 12680738